✦ LIBER ✦

Post-treatment emergent adverse events in depressed patients following treatment with milnacipran and paroxetine

✍ Scribed by P. Vandel; D. Sechter; E. Weiller; N. Pezous; F. Cabanac; A. Tournoux; E. Panconi

Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 41 KB
Volume: 19
Category: Article
ISSN: 0885-6222
DOI: 10.1002/hup.644

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Paroxetine in the treatment of depressed

Paroxetine in the treatment of depressed patients with haematological malignancy: an open-label study

✍ Chi-Un Pae; Yoo-Jin Kim; Wang-Youn Won; Hee-Je Kim; Seok Lee; Chang-Uk Lee; Soo- 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB 👁 2 views

## Abstract ## Objective The efficacy and tolerability of paroxetine in the treatment of depressive disorders is well known, however, its efficacy and safety for the treatment of depression in patients with cancer has been poorly studied. Therefore this study was aimed at evaluating the efficacy a

Relative association of treatment-emerge

Relative association of treatment-emergent adverse events with quality of life of patients with schizophrenia: post hoc analysis from a 3-year observational study

✍ Cecilia Adrianzén; Cesar Arango-Dávila; Danilo Martínez Araujo; Ignacio Ruíz; Ri 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB 👁 1 views

## Abstract ## Objective To explore the relative association of adverse events with health‐related quality of life (HRQL) in patients (__N__ = 16 091) with schizophrenia, treated with antipsychotic medication. ## Methods In this __post hoc__ analysis of data from two 3‐year observational studies

Platelet 5-HT uptake sites, labelled wit

Platelet 5-HT uptake sites, labelled with [3H] paroxetine, in controls and depressed patients before and after treatment with fluoxetine or lofepramine

✍ Kevin M. Lawrence; Cornelius L. E. Katona; Mohammed T. Abou-Saleh; Mary M. Rober 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 535 KB

Etanercept and adalimumab treatment in p

Etanercept and adalimumab treatment in patients with rheumatoid arthritis and spondyloarthropathies in clinical practice: adverse events and other reasons leading to discontinuation of the treatment

✍ Tiina Levälampi; Markku Korpela; Katriina Vuolteenaho; Eeva Moilanen 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 341 KB

Rapid response to paroxetine is associat

Rapid response to paroxetine is associated with plasma paroxetine levels at 4 but not 8 weeks of treatment, and is independent of serotonin transporter promoter polymorphism in Japanese depressed patients

✍ Reiji Yoshimura; Wakako Umene-Nakano; Akihito Suzuki; Nobuhisa Ueda; Kyoko Miyam 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 1 views

## Abstract In the present study, we investigated the relationship between the serotonin transporter gene linked polymorphic regions (5‐HTTLPR) or plasma paroxetine levels and clinical response to paroxetine in depressed patients. Sixty patients who met the DSM‐IV criteria for major depressive diso

Evaluation of a latex agglutination test

Evaluation of a latex agglutination test (KAtex) for detection ofLeishmaniaantigen in urine of patients with HIV-Leishmaniacoinfection: value in diagnosis and post-treatment follow-up

✍ C. Riera; R. Fisa; P. Lopez; E. Ribera; J. Carrió; V. Falcó; I. Molina; M. Gálle 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 85 KB